- Home
- INO vs MATH Comparison
INO vs MATH Comparison
Compare INO & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- MATH
- Stock Information
- Founded
- INO 1979
- MATH 2015
- Country
- INO United States
- MATH Hong Kong
- Employees
- INO N/A
- MATH N/A
- Industry
- INO Medical/Dental Instruments
- MATH Finance/Investors Services
- Sector
- INO Health Care
- MATH Finance
- Exchange
- INO Nasdaq
- MATH Nasdaq
- Market Cap
- INO 69.3M
- MATH 60.8M
- IPO Year
- INO 1998
- MATH N/A
- Fundamental
- Price
- INO $2.18
- MATH $3.35
- Analyst Decision
- INO Buy
- MATH
- Analyst Count
- INO 5
- MATH 0
- Target Price
- INO $8.80
- MATH N/A
- AVG Volume (30 Days)
- INO 2.1M
- MATH 152.2K
- Earning Date
- INO 11-13-2025
- MATH 10-30-2025
- Dividend Yield
- INO N/A
- MATH N/A
- EPS Growth
- INO N/A
- MATH N/A
- EPS
- INO N/A
- MATH 0.41
- Revenue
- INO $182,337.00
- MATH $44,567,257.00
- Revenue This Year
- INO N/A
- MATH N/A
- Revenue Next Year
- INO $15,960.33
- MATH N/A
- P/E Ratio
- INO N/A
- MATH $8.22
- Revenue Growth
- INO N/A
- MATH 165.86
- 52 Week Low
- INO $1.30
- MATH $0.88
- 52 Week High
- INO $7.00
- MATH $4.17
- Technical
- Relative Strength Index (RSI)
- INO 47.09
- MATH 55.21
- Support Level
- INO $2.33
- MATH $2.96
- Resistance Level
- INO $2.98
- MATH $3.65
- Average True Range (ATR)
- INO 0.20
- MATH 0.26
- MACD
- INO -0.07
- MATH 0.04
- Stochastic Oscillator
- INO 2.44
- MATH 64.71
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.